- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 21.77M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 21.93M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 16.02M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.32K |
| Capex | Q1 2026 · Mar 31, 2025 | $63.27K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$11.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.04M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $54.25M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $66.05M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $57.46M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $62.53M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $38.5M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $39.09M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $5.43M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $9.13M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $11.79M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $17.2M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $68.56M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $79.01M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $69.25M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $79.73M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.32 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.30 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $10.26M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $5.09M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.1M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $400.42K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.48M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$1.73M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$8.1M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$3.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.53M |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.93M |